# Myers Industries Inc: overview

MYE · NYSE · CIK 69488 · [Consumer discretionary](/sectors/consumer-discretionary.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/mye.md) · [Financials](/companies/mye/financials.md) · [Filings](/companies/mye/filings.md) · [Insiders](/companies/mye/insiders.md)

Latest reported revenue: [$179.2m](/filings/0001193125-26-324876.md) for Q2 FY2026, three months to 2026-06-30, from the 10-Q filed Jul 30, 2026 (XBRL us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax, accession 0001193125-26-324876).

## Last eight quarters

| Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [205](/filings/0001193125-25-258507.md) | [204 d](/filings/0001193125-26-092521.md) | [162](/filings/0001193125-26-210311.md) | [163](/filings/0001193125-26-324876.md) | [205](/filings/0001193125-25-258507.md) | [204 d](/filings/0001193125-26-092521.md) | [165](/filings/0001193125-26-210311.md) | [179](/filings/0001193125-26-324876.md) |
| Gross margin | % | [31.8%](/filings/0001193125-25-258507.md) | [32.3% d](/filings/0001193125-26-092521.md) | [31.1%](/filings/0001193125-26-210311.md) | [31.3%](/filings/0001193125-26-324876.md) | [33.4%](/filings/0001193125-25-258507.md) | [33.2% d](/filings/0001193125-26-092521.md) | [34.4%](/filings/0001193125-26-210311.md) | [34.3%](/filings/0001193125-26-324876.md) |
| Operating margin | % | [(2.3%)](/filings/0001193125-25-258507.md) | [7.2% d](/filings/0001193125-26-092521.md) | [10.6%](/filings/0001193125-26-210311.md) | [12.2%](/filings/0001193125-26-324876.md) | [8.6%](/filings/0001193125-25-258507.md) | [9.9% d](/filings/0001193125-26-092521.md) | [15.1%](/filings/0001193125-26-210311.md) | [17.4%](/filings/0001193125-26-324876.md) |
| Net margin | % | [(5.3%)](/filings/0001193125-25-258507.md) | [2.1% d](/filings/0001193125-26-092521.md) | [4.2%](/filings/0001193125-26-210311.md) | [5.9%](/filings/0001193125-26-324876.md) | [3.5%](/filings/0001193125-25-258507.md) | [5.6% d](/filings/0001193125-26-092521.md) | [(1.1%)](/filings/0001193125-26-210311.md) | [11.2%](/filings/0001193125-26-324876.md) |
| Diluted EPS | $ per share | [(0.29)](/filings/0001193125-25-258507.md) | not reported | [0.18](/filings/0001193125-26-210311.md) | [0.26](/filings/0001193125-26-324876.md) | [0.19](/filings/0001193125-25-258507.md) | not reported | [(0.05)](/filings/0001193125-26-210311.md) | [0.53](/filings/0001193125-26-324876.md) |
| Free cash flow | $m | [10.1 d](/filings/0001193125-25-258507.md) | [20.2 d](/filings/0001193125-26-092521.md) | [2.1](/filings/0001193125-26-210311.md) | [24.8 d](/filings/0001193125-26-324876.md) | [21.4 d](/filings/0001193125-25-258507.md) | [18.9 d](/filings/0001193125-26-092521.md) | [23.4](/filings/0001193125-26-210311.md) | [27.9 d](/filings/0001193125-26-324876.md) |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure.

## Last five fiscal years

| Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [761](/filings/0000950170-24-025847.md) | [900](/filings/0000950170-25-034598.md) | [813](/filings/0001193125-26-092521.md) | [836](/filings/0001193125-26-092521.md) | [826](/filings/0001193125-26-092521.md) |
| Gross margin | % | [27.8%](/filings/0000950170-24-025847.md) | [31.5%](/filings/0000950170-25-034598.md) | [31.9%](/filings/0001193125-26-092521.md) | [32.4%](/filings/0001193125-26-092521.md) | [33.4%](/filings/0001193125-26-092521.md) |
| Operating margin | % | [6.5%](/filings/0000950170-24-025847.md) | [9.3%](/filings/0000950170-25-034598.md) | [8.9%](/filings/0001193125-26-092521.md) | [5.3%](/filings/0001193125-26-092521.md) | [9.0%](/filings/0001193125-26-092521.md) |
| Net margin | % | [4.4%](/filings/0000950170-24-025847.md) | [6.7%](/filings/0000950170-25-034598.md) | [6.0%](/filings/0001193125-26-092521.md) | [0.9%](/filings/0001193125-26-092521.md) | [4.2%](/filings/0001193125-26-092521.md) |
| Diluted EPS | $ per share | [0.92](/filings/0000950170-24-025847.md) | [1.64](/filings/0000950170-25-034598.md) | [1.32](/filings/0001193125-26-092521.md) | [0.19](/filings/0001193125-26-092521.md) | [0.93](/filings/0001193125-26-092521.md) |
| Free cash flow | $m | [27.0](/filings/0000950170-24-025847.md) | [48.3](/filings/0000950170-25-034598.md) | [63.3](/filings/0001193125-26-092521.md) | [54.9](/filings/0001193125-26-092521.md) | [67.2](/filings/0001193125-26-092521.md) |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/mye/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [GAMCO INVESTORS, INC. ET AL](/funds/807249.md) | 2026-06-30 | $119.1m | 3,374,319 |  | Reduced −55,401 |
| [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $104.2m | 2,949,900 |  | Added +208,260 |
| [ADVISORY RESEARCH INC](/funds/902584.md) | 2026-06-30 | $65.6m | 1,857,873 |  | Added +332,157 |
| [Capital World Investors](/funds/1422849.md) | 2026-06-30 | $63.3m | 1,793,102 |  | Added +48,918 |
| [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $58.6m | 1,659,531 |  | Added +31,067 |
| [DIMENSIONAL FUND ADVISORS LP](/funds/354204.md) | 2026-06-30 | $58.0m | 1,644,211 |  | Added +54,791 |
| [GABELLI FUNDS LLC](/funds/1081407.md) | 2026-06-30 | $50.9m | 1,442,650 |  | Reduced −55,500 |
| [Allspring Global Investments Holdings, LLC](/funds/1890906.md) | 2026-06-30 | $47.7m | 1,400,451 |  | Reduced −661,389 |
| [FMR LLC](/funds/315066.md) | 2026-06-30 | $45.3m | 1,283,023 |  | Added +1,110,567 |
| [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $40.7m | 1,152,257 |  | Added +68,548 |

## Recent filings

[All 1,057 filings](/companies/mye/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-29 | 07:05 ET | [8-K](/filings/0001193125-26-436960.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-436960 |
| 2026-10-23 | 16:05 ET | [8-K](/filings/0001193125-26-430415.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-26-430415 |
| 2026-08-31 | 16:05 ET | [8-K](/filings/0001193125-26-376721.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-376721 |
| 2026-08-03 | 16:03 ET | [SCHEDULE 13D/A](/filings/0000807249-26-000059.md) | Ownership report, active investor, amended | 0000807249-26-000059 |
| 2026-07-30 | 07:10 ET | [10-Q](/filings/0001193125-26-324876.md) | Quarterly report, period 2026-06-30 | 0001193125-26-324876 |
| 2026-07-30 | 07:05 ET | [8-K](/filings/0001193125-26-324868.md) | 1.01 Entry into a material agreement; 2.02 Results of operations; 2.03 New direct financial obligation; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-324868 |
| 2026-05-07 | 07:10 ET | [10-Q](/filings/0001193125-26-210311.md) | Quarterly report, period 2026-03-31 | 0001193125-26-210311 |
| 2026-05-07 | 07:05 ET | [8-K](/filings/0001193125-26-210296.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-210296 |
| 2026-04-24 | 16:30 ET | [8-K](/filings/0001193125-26-177402.md) | 5.07 Shareholder vote results | 0001193125-26-177402 |
| 2026-03-13 | 16:00 ET | [DEF 14A](/filings/0001193125-26-106082.md) | Proxy statement, period 2026-03-13 | 0001193125-26-106082 |

## Latest annual report

[Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001193125-26-092521.md), filed Mar 5, 2026.

## Forecast league

Q3 FY2026, the quarter ended 2026-09-30, locked when the 8-K was accepted. It is scored when the 10-Q or 10-K is ingested. [See the target](/leagues/2026q3/targets/fa0860bf-9088-4e7c-8e9b-2a2bd4a17c2e)

## About the filer

- CIK: 69488
- Tickers: MYE
- Exchange: NYSE
- SIC code: 3089 Plastics Products, NEC
- State of incorporation: OH
- Filer category: Accelerated filer

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 29, 2026, 07:11 ET. No prices; not investment advice.